Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Entacingene turiparvovec by MeiraGTx for Achromatopsia: Likelihood of Approval
Entacingene turiparvovec is under clinical development by MeiraGTx and currently in Phase II for Achromatopsia. According to GlobalData, Phase II...